Suppr超能文献

少突胶质细胞瘤的影像学特征可预测肿瘤级别。

Imaging characteristics of oligodendrogliomas that predict grade.

机构信息

Russell H. Morgan Department of Radiology and Radiological Services, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.

出版信息

AJNR Am J Neuroradiol. 2012 May;33(5):852-7. doi: 10.3174/ajnr.A2895. Epub 2012 Jan 19.

Abstract

BACKGROUND AND PURPOSE

Oligodendrogliomas are tumors that have variable WHO grades depending on anaplasia and astrocytic components and their treatment may differ accordingly. Our aim was to retrospectively evaluate imaging features of oligodendrogliomas that predict tumor grade.

MATERIALS AND METHODS

The imaging studies of 75 patients with oligodendrogliomas were retrospectively reviewed and compared with the histologic grade. The presence and degree of enhancement and calcification were evaluated subjectively. rCBV and ADC maps were measured. Logistic linear regression models were used to determine the relationship between imaging factors and tumor grade.

RESULTS

Thirty of 75 (40%) tumors enhanced, including 9 of 46 (19.6%) grade II and 21 of 29 (72.4%) grade III tumors (P < .001). Grade III tumors showed lower ADC values compared with grade II tumors (odds ratio of a tumor being grade III rather than grade II = 0.07; 95% CI, 0.02-0.25; P = .001). An optimal ADC cutoff of 925 10(-6) mm(2)/s was established, which yielded a specificity of 89.1%, sensitivity of 62.1%, and accuracy of 78.7%. There was no statistically significant association between tumor grade and the presence of calcification and perfusion values. Multivariable prediction rules were applied for ADC < 925 10(-6) mm(2)/s, the presence of enhancement, and the presence of calcification. If either ADC < 925 10(-6) mm(2)/s or enhancement was present, it yielded 93.1% sensitivity, 73.9% specificity, and 81.3% accuracy. The most accurate (82.2%) predictive rule was seen when either ADC < 925 10(-6) mm(2)/s or enhancement and calcification were present.

CONCLUSIONS

Models based on contrast enhancement, calcification, and ADC values can assist in predicting the grade of oligodendrogliomas and help direct biopsy sites, raise suspicion of sampling error, and predict prognosis.

摘要

背景与目的

少突胶质细胞瘤的组织学分级取决于间变程度和星形细胞成分,其表现为不同的世界卫生组织分级,治疗方法也因此有所不同。本研究旨在回顾性分析少突胶质细胞瘤的影像学特征,以预测肿瘤分级。

材料与方法

回顾性分析了 75 例少突胶质细胞瘤患者的影像学资料,并与组织学分级进行比较。评估了增强程度和钙化程度。测量了 rCBV 和 ADC 图。采用逻辑线性回归模型确定影像学因素与肿瘤分级的关系。

结果

75 例肿瘤中,30 例(40%)增强,其中 46 例 II 级肿瘤中有 9 例(19.6%),29 例 III 级肿瘤中有 21 例(72.4%)增强(P <.001)。III 级肿瘤的 ADC 值低于 II 级肿瘤(肿瘤为 III 级的几率比为 0.07;95%CI,0.02-0.25;P =.001)。确定了 ADC 最佳截断值为 925×10(-6)mm(2)/s,其特异性为 89.1%,敏感性为 62.1%,准确性为 78.7%。肿瘤分级与钙化和灌注值之间无统计学相关性。多变量预测规则适用于 ADC < 925×10(-6)mm(2)/s、增强和钙化。如果 ADC < 925×10(-6)mm(2)/s 或增强存在,其敏感性为 93.1%,特异性为 73.9%,准确性为 81.3%。当 ADC < 925×10(-6)mm(2)/s 或增强和钙化存在时,预测规则最准确(82.2%)。

结论

基于对比增强、钙化和 ADC 值的模型可辅助预测少突胶质细胞瘤的分级,有助于指导活检部位,提高对取样误差的警惕性,并预测预后。

相似文献

1
Imaging characteristics of oligodendrogliomas that predict grade.
AJNR Am J Neuroradiol. 2012 May;33(5):852-7. doi: 10.3174/ajnr.A2895. Epub 2012 Jan 19.
4
Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas.
J Neuroimaging. 2016 May;26(3):366-71. doi: 10.1111/jon.12320. Epub 2015 Dec 26.
8
Genetically Defined Oligodendroglioma Is Characterized by Indistinct Tumor Borders at MRI.
AJNR Am J Neuroradiol. 2017 Apr;38(4):678-684. doi: 10.3174/ajnr.A5070. Epub 2017 Jan 26.
10
Differential diagnosis of oligodendroglial and astrocytic tumors using imaging results: the added value of perfusion MR imaging.
Neuroradiology. 2017 Jul;59(7):665-675. doi: 10.1007/s00234-017-1851-x. Epub 2017 May 26.

引用本文的文献

1
IDH mutant high-grade gliomas.
Front Mol Neurosci. 2025 Aug 29;18:1662414. doi: 10.3389/fnmol.2025.1662414. eCollection 2025.
3
Prognostic and clinical significance of contrast enhancement in WHO grade 2 oligodendrogliomas.
J Neurooncol. 2025 Apr;172(2):481-490. doi: 10.1007/s11060-024-04929-3. Epub 2025 Jan 19.
7
Intratumoral calcification: not only a diagnostic but also a prognostic indicator in oligodendrogliomas.
Eur Radiol. 2024 Jun;34(6):3674-3685. doi: 10.1007/s00330-023-10405-9. Epub 2023 Nov 16.
8
Malignant Glioma.
Adv Exp Med Biol. 2023;1405:1-30. doi: 10.1007/978-3-031-23705-8_1.
10
Adult-type and Pediatric-type Diffuse Gliomas : What the Neuroradiologist Should Know.
Clin Neuroradiol. 2023 Sep;33(3):611-624. doi: 10.1007/s00062-023-01277-z. Epub 2023 Mar 20.

本文引用的文献

2
Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging.
J Neurooncol. 2009 Aug;94(1):87-96. doi: 10.1007/s11060-009-9807-6. Epub 2009 Feb 20.
3
Relative cerebral blood volume measurements of low-grade gliomas predict patient outcome in a multi-institution setting.
Eur J Radiol. 2010 Feb;73(2):215-20. doi: 10.1016/j.ejrad.2008.11.005. Epub 2009 Feb 6.
4
Identification of calcification with MRI using susceptibility-weighted imaging: a case study.
J Magn Reson Imaging. 2009 Jan;29(1):177-82. doi: 10.1002/jmri.21617.
5
Time trends in oligodendroglial and astrocytic tumor incidence.
Neuroepidemiology. 2008;30(1):34-44. doi: 10.1159/000115440. Epub 2008 Feb 6.
7
The 2007 WHO classification of tumours of the central nervous system.
Acta Neuropathol. 2007 Aug;114(2):97-109. doi: 10.1007/s00401-007-0243-4. Epub 2007 Jul 6.
8
Cerebral blood volume measurements and proton MR spectroscopy in grading of oligodendroglial tumors.
AJR Am J Roentgenol. 2007 Jan;188(1):204-12. doi: 10.2214/AJR.05.1177.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验